DAGCO, Inc.

SEC CIK: 0001767343
Latest filing: Jul 10, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by DAGCO, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of RXRX by DAGCO, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−100−100.0%	Sold out	Holders
Q1 2025	100	$529	<0.1%	+100	New	Holders
Q4 2024	0	$0	0.0%	−100−100.0%	Sold out	Holders
Q3 2024	100	$659	<0.1%	+100	New	Holders